C50.9
Conditions
Interventions
Group 1: Patients with invasive breast cancer undergoing oral tumor therapy - As part of the study, the treatment team is provided with the browser-based OnkoPass dashboard, which supports therapy man
Sponsors
Department für Frauengesundheit
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: ? HR+/HER2- breast cancer ? Patients in the adjuvant therapy phase without metastasis (M0) undergoing oral tumor therapy ? Invasive breast cancer with metastasis (M1) undergoing oral tumor therapy ? Maximum of one prior endocrine therapy in the M1 situation ? Ongoing therapy with a CDK4/6 inhibitor in combination with an aromatase inhibitor for at least 3 months ? Stable disease ? Most recent CT scan as part of routine clinical care no more than 4 weeks ago ? Computer, tablet, or smartphone with internet access ? Signed informed consent form
Exclusion criteria
Exclusion criteria: ? Patients for whom study participation is deemed unreasonable by the treating physician due to severely limited life expectancy or serious comorbidities. ? Patients who, due to psychological or cognitive impairments, are not considered capable of giving informed consent and cooperating, as assessed by the treating physician ? Patients who have not signed the informed consent form or have not agreed to the data protection regulations.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation and comparison of user satisfaction with treatment, both without and with the use of OnkoPass, as reported by the treatment team and study participants | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of the time expenditure by the treatment team to determine the extent to which the use of the digital monitoring and support platform OnkoPass enables time savings and more efficient use of resources | — |
Countries
Germany
Contacts
Public ContactAndreas Hartkopf
Department für Frauengesundheit
Outcome results
None listed